Versant Ventures
Guido Magni is a Partner at Versant Ventures. Prior to joining Versant Ventures, Guido was the head of medical science WW, global drug development at Roche Pharmaceuticals. Guido holds an M.D. and Ph.D. in medicine and neuropharmacology from Università degli Studi di Padova.
This person is not in the org chart
This person is not in any offices
Versant Ventures
1 followers
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.